Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000950170-25-093444
Filing Date
2025-07-03
Accepted
2025-07-02 20:00:28
Documents
10
Period of Report
2025-04-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K/A amrn-20250404.htm   iXBRL 8-K/A 54427
  Complete submission text file 0000950170-25-093444.txt   178598

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT amrn-20250404.xsd EX-101.SCH 34109
13 EXTRACTED XBRL INSTANCE DOCUMENT amrn-20250404_htm.xml XML 5831
Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-21392 | Film No.: 251103429
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)